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SummAry Scleredema adultorum (SA) is a rare sclerotic disorder charac-
terized by non-pitting induration of the neck with acral progression, spar-
ing hands and feet. We report on a 57-year-old male with severe SA associ-
ated with paraproteinemia, treated with methotrexate. Such widespread 
skin thickening followed by severe movement restriction and inability to 
function on daily basis, as in our patient, has never been described. Se-
vere osteoarthritis and finding of HLA-B39 allele in association with SA has 
not been previously described either. To the best of our knowledge, up to 
40 patients with SA associated with paraproteinemia has been reported 
so far, and currently, there is no established effective treatment protocol. 
In our patient, low-dose methotrexate resulted in stiffness reduction, in-
creased motility of the trunk and extremities, and ability to function on 
daily basis. We believe that any information about treatment outcome in 
SA patients should be disseminated in order to establish consensual treat-
ment protocol for this rare disease.
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IntrOduCtIOn
Scleredema adultorum (SA) is a rare sclerotic dis-
order characterized by diffuse swelling and non-pit-
ting induration of the skin due to thickening of the 
dermis (1,2). Occurrence of SA has been documented 
in association with infections (type 1), paraprotein-
emia (type 2) and diabetes mellitus (type 3) (1,3). 
Women are diagnosed with type 1 and type 2 SA ap-
proximately twice as frequently as men (1). The SA 
may be self-limiting, but in patients with progressive 
disease, therapeutic options are poor. The presence 
of HLA-B39 allele may be associated with severe os-
teoarticular affection (4,5). 
We report on a patient with SA associated with 
paraproteinemia, HLA-B39 allele and severe osteoar-
thritis. Such marked restriction of the spine, arm and 
leg movements due to widespread skin stiffness as-
sociated with osteoarthritis as in our patient has nev-
er been described. After 4-week therapy, low-dose 
methotrexate induced regression of stiffness and led 
to increased mobility of the trunk and extremities.
CASe rePOrt 
A 57-year-old male presented with 2-year history 
of painless, progressive, widespread skin thickening, 
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woody induration of the skin on the neck, shoulders, 
trunk, arms, and legs (Fig. 1). Skin thickening and stiff-
ness appeared gradually during two to three months. 
His face, hands and feet were spared; Raynaud’s phe-
nomenon and telangiectasia were absent. Widespread 
stiffness led to marked restriction of the spine, arm and 
leg movement (Fig. 2) and impaired thoracic move-
ments with moderate restrictive ventilatory defect. 
He had personal history of generalized osteoar-
thritis and coxarthrosis complicated with lesions of 
peripheral nerves, alcoholism, osteopenia, compres-
sive fractures of L 3-4 and severe obstructive sleep 
apnea syndrome. During one year, he was observed 
at Rheumatology Department as possible eosinophil-
ic fasciitis (EF) and was treated with low to moderate 
dose of prednisone. In the absence of relevant labora-
tory finding supporting EF diagnosis, normal finding 
of deep muscle biopsy and failure of corticosteroid 
therapy, the patient was referred to dermatologist.
At presentation, there were no abnormalities in 
complete blood count, serum and urine biochemi-
cal analysis except for decreased serum protein level 
(54g/L), with slightly reduced beta 1 (5.5%) globulin 
fraction. Antinuclear antibodies were negative; CH50, 
circulating immune complexes and immunoglobulin 
level were normal. HLA typing revealed HLA-A3/23; 
HLA-B39/44 alleles.
Skin biopsy (alcian blue pH 2.5) revealed minimal 
epidermal changes and a markedly thickened dermis 
with swollen and separated collagen fibers (Fig. 3). 
Congo red and toluidine blue staining were negative. 
The diagnosis of monoclonal gammopathy of un-
determined significance (MGUS) was made based on 
the finding of paraprotein of the IgG lambda type in 
urine and serum, and absence of malignant cells in 
bone marrow.
Four-week methotrexate (10 mg/week) was re-
sulted in significant regression of induration on the 
Figure 1. Maximal extension of the trunk and extre-
mities due to widespread skin thickening and severe 
osteoarthritis.
Figure 2. Maximal adduction of upper and lower 
limbs.
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neck, shoulders and upper extremities, with increased 
motility of the shoulder and arms. After four-month 
treatment, stiffness of the upper parts of lower ex-
tremities was also reduced. 
dISCuSSIOn
Scleredema adultorum is a rare sclerotic disease 
characterized by non-pitting induration of the neck 
with acral progression, sparing hands and feet. The 
absence of Raynaud’s phenomenon and visceral in-
volvement permits clinical differentiation of this rare 
disease from systemic sclerosis (2,3). 
In our patient, the diagnosis of SA was established 
since clinical and paraclinical findings indicated ab-
sence of systemic involvement, deep muscle biopsy 
demonstrated normal finding, and skin histopathol-
ogy indicated mucin deposits in the dermis.
Such widespread skin thickening followed by re-
striction of trunk and extremity movements as in our 
patient has never been described. In most patients, 
SA tends to be localized (6), while type 2 SA tends to 
assume a progressive course (7). 
Severe obstructive sleep apnea syndrome is re-
ported in 25% of SA patients (6). Paraproteinemia is 
also found in 25% of SA patients. It has already been 
documented that MGUS frequently precedes mul-
tiple myeloma and that patients with SA tend to have 
a more aggressive and rapidly progressive multiple 
myeloma (7). Therefore, patients with SA associated 
with paraproteinemia should be carefully followed by 
hematologists.
According to the available data, numerous thera-
pies for SA have been tried including pituitary extract 
(1), thyroid hormone (1), colchicine (3), methotrex-
ate (8), antibiotics (1), corticosteroids (1,3), electron 
beam therapy (3,9), physiotherapy (1,3), photophere-
sis (1,3), and phototherapy with psoralen (1,3), but 
none has proved consistently effective (9).
To the best of our knowledge, up to 40 patients 
with scleredema associated with paraproteinemia 
have been reported. According to literature data, 
only one patient with type 3 SA treated with low-dose 
methotrexate partially responded to therapy (8). In 
our patient, low-dose methotrexate led to reduced 
skin thickening and better mobility of the shoulder, 
upper and lower extremities. The finding of HLA-B39 
allele has not been reported so far in SA patients and 
may explain development of severe osteoarticular 
manifestation in our patient (4).
We believe that all information about successful 
treatment outcome in SA patients may expand the 
available data pool and provide more management 
options to physicians. 
COnCLuSIOn
We present a severe type 2 SA in an HLA-B39 posi-
tive male. In our patient, the association of SA and 
severe osteoarthritis led to reduced motility of the 
trunk and extremities and inability to function on a 
daily basis. Treatment with methotrexate resulted in 
increased motility and improved his quality of life. 
In order to establish consensual treatment proto-
col for this rare disease and to improve patient quality 
of life, any information about treatment outcome in 
patients with SA should be disseminated.
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